Page last updated: 2024-08-24

cidofovir anhydrous and Anogenital Type Verrucous Carcinoma

cidofovir anhydrous has been researched along with Anogenital Type Verrucous Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anton, K; Das, BB; Jarin, J; Knox, L; Sue, PK	1
Bleday, R; Fisher, DC; Mutyambizi, K; Nambudiri, VE; Saavedra, AP; Walls, AC	1
Gormley, RH; Kovarik, CL	1

Reviews

1 review(s) available for cidofovir anhydrous and Anogenital Type Verrucous Carcinoma

Article	Year
Human papillomavirus-related genital disease in the immunocompromised host: Part II. Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6 Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts	2012

Article

Year

Human papillomavirus-related genital disease in the immunocompromised host: Part II.

Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:6

Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts

2012

Other Studies

2 other study(ies) available for cidofovir anhydrous and Anogenital Type Verrucous Carcinoma

Article	Year
Successful treatment of giant condyloma in a pediatric heart transplant recipient with topical cidofovir. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:6 Topics: Antiviral Agents; Buschke-Lowenstein Tumor; Child, Preschool; Cidofovir; Female; Heart Transplantation; Human papillomavirus 6; Humans; Immunosuppression Therapy; Photography; Skin; Skin Neoplasms; Treatment Outcome	2018
Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir. JAMA dermatology, 2013, Volume: 149, Issue:9 Topics: Administration, Topical; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Cidofovir; Combined Modality Therapy; Cytosine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunocompromised Host; Interleukin-2; Male; Middle Aged; Neoplasm Recurrence, Local; Organophosphonates; Treatment Outcome	2013

Article

Year

Successful treatment of giant condyloma in a pediatric heart transplant recipient with topical cidofovir.

Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:6

Topics: Antiviral Agents; Buschke-Lowenstein Tumor; Child, Preschool; Cidofovir; Female; Heart Transplantation; Human papillomavirus 6; Humans; Immunosuppression Therapy; Photography; Skin; Skin Neoplasms; Treatment Outcome

2018

Successful treatment of perianal giant condyloma acuminatum in an immunocompromised host with systemic interleukin 2 and topical cidofovir.

JAMA dermatology, 2013, Volume: 149, Issue:9

Topics: Administration, Topical; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Cidofovir; Combined Modality Therapy; Cytosine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunocompromised Host; Interleukin-2; Male; Middle Aged; Neoplasm Recurrence, Local; Organophosphonates; Treatment Outcome

2013